// App-Quantinova.ai

101.0 : The potential drug cost impact of nivolumab (N) in patients with advanced/metastatic gastric cancer (GC) or gastroesophageal junction cancer (GEJC) in Canada.

Researchers

Presenter

  • Kiran Virik

Principal Investigators

  • Robert B Wilson

Medical Centers

  • Queen's University/Cancer Centre of SE Ontario, Kingston, ON, Canada

  • University of NSW, Sydney, Australia

Locations

  • Canada

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Gastroesophageal junction (GEJ) adenocarcinoma

  • Gastric Cancer

  • Lung Cancer

Biomarkers

  • N/A

Drug/Treatment

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved